The Houston, TX-based company said it will begin a first-in-human study of the Bivacor Total Artificial Heart.
Effective ‘People Strategy’ for Start-UpsNov 30, 2023
Medtronic CEO: China VBP Impact Is ‘Largely Behind Us’Nov 29, 2023
Bivacor Keeps Total Artificial Heart Market Pumping with IDENov 29, 2023
Your AI Initiative is Likely to FailNov 29, 2023